- Home
- AUPH vs STAA Comparison
AUPH vs STAA Comparison
Compare AUPH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- STAA
- Stock Information
- Founded
- AUPH 1993
- STAA 1982
- Country
- AUPH Canada
- STAA United States
- Employees
- AUPH N/A
- STAA N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- STAA Ophthalmic Goods
- Sector
- AUPH Health Care
- STAA Health Care
- Exchange
- AUPH Nasdaq
- STAA Nasdaq
- Market Cap
- AUPH 1.1B
- STAA 1.2B
- IPO Year
- AUPH 1999
- STAA N/A
- Fundamental
- Price
- AUPH $8.05
- STAA $17.60
- Analyst Decision
- AUPH Strong Buy
- STAA Buy
- Analyst Count
- AUPH 2
- STAA 9
- Target Price
- AUPH $11.50
- STAA $30.71
- AVG Volume (30 Days)
- AUPH 1.4M
- STAA 1.0M
- Earning Date
- AUPH 05-01-2025
- STAA 05-06-2025
- Dividend Yield
- AUPH N/A
- STAA N/A
- EPS Growth
- AUPH N/A
- STAA N/A
- EPS
- AUPH 0.04
- STAA N/A
- Revenue
- AUPH $235,133,000.00
- STAA $313,901,000.00
- Revenue This Year
- AUPH $11.86
- STAA N/A
- Revenue Next Year
- AUPH $24.96
- STAA $25.89
- P/E Ratio
- AUPH $201.00
- STAA N/A
- Revenue Growth
- AUPH 33.97
- STAA N/A
- 52 Week Low
- AUPH $4.71
- STAA $13.50
- 52 Week High
- AUPH $10.67
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- AUPH 44.83
- STAA 44.92
- Support Level
- AUPH $7.93
- STAA $17.34
- Resistance Level
- AUPH $8.73
- STAA $17.98
- Average True Range (ATR)
- AUPH 0.23
- STAA 0.80
- MACD
- AUPH -0.04
- STAA 0.11
- Stochastic Oscillator
- AUPH 15.00
- STAA 53.24
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.